Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Atay

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
JTCVS Techniques|October 31, 2024
Esophageal perforation secondary to esophageal gastrointestinal stromal tumorMegha Sheth, Scott M Atay, Sean C Wightman, et al.
Seminars in Thoracic and Cardiovascular Surgery|June 21, 2019
Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung CancerJason C Ye, Li Ding, Scott M Atay, et al.
Clinical Transplantation|January 1, 2023
Heart transplantation for pediatric foreign nationals in the United StatesTakashi Harano, Megha Sheth, Kazunari Sasaki, et al.
JTCVS Open|April 10, 2026
Framework for estimating the financial contribution of a benign foregut practice: What general thoracic surgeons need to knowArman Ashrafi, Brooks V Udelsman, Graeme M Rosenberg, et al.
JTO Clinical and Research Reports|September 30, 2021
Exploring the Potential Different Outcomes Associated With the Different Phenotypes Under the Shared Pathologic T3N0 DesignationTerrance Peng, Sean C Wightman, Li Ding, et al.
JTCVS Open|August 25, 2022
Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non-small cell lung cancer tumorsTerrance Peng, Sean C Wightman, Li Ding, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 25, 2023
Early outcomes of lung transplantation with lung allografts from coronavirus disease 2019 (COVID-19)-positive donorsJae Hyun Jeon, Takashi Harano, John C S Rodman, et al.
Journal of Thoracic Disease|June 24, 2021
Differential outcomes of residual disease in surgically-resected non-small cell lung cancer and the importance of guideline-concordant adjuvant therapyDustin K Lieu, Li Ding, Elizabeth A David, et al.
Seminars in Thoracic and Cardiovascular Surgery|October 22, 2022
Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trialOmar Toubat, Li Ding, Keyue Ding, et al.
American Journal of Clinical Oncology|March 23, 2022
Patterns of Use of Stereotactic Body Radiation Therapy Compared With Surgery for Definitive Treatment of Primary Early-stage Non-small Cell Lung CancerJulie K Jang, Scott M Atay, Li Ding, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
JTCVS Techniques|October 31, 2024
Esophageal perforation secondary to esophageal gastrointestinal stromal tumorMegha Sheth, Scott M Atay, Sean C Wightman, et al.
Seminars in Thoracic and Cardiovascular Surgery|June 21, 2019
Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung CancerJason C Ye, Li Ding, Scott M Atay, et al.
Clinical Transplantation|January 1, 2023
Heart transplantation for pediatric foreign nationals in the United StatesTakashi Harano, Megha Sheth, Kazunari Sasaki, et al.
JTCVS Open|April 10, 2026
Framework for estimating the financial contribution of a benign foregut practice: What general thoracic surgeons need to knowArman Ashrafi, Brooks V Udelsman, Graeme M Rosenberg, et al.
JTO Clinical and Research Reports|September 30, 2021
Exploring the Potential Different Outcomes Associated With the Different Phenotypes Under the Shared Pathologic T3N0 DesignationTerrance Peng, Sean C Wightman, Li Ding, et al.
JTCVS Open|August 25, 2022
Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non-small cell lung cancer tumorsTerrance Peng, Sean C Wightman, Li Ding, et al.
The Journal of Thoracic and Cardiovascular Surgery|August 25, 2023
Early outcomes of lung transplantation with lung allografts from coronavirus disease 2019 (COVID-19)-positive donorsJae Hyun Jeon, Takashi Harano, John C S Rodman, et al.
Journal of Thoracic Disease|June 24, 2021
Differential outcomes of residual disease in surgically-resected non-small cell lung cancer and the importance of guideline-concordant adjuvant therapyDustin K Lieu, Li Ding, Elizabeth A David, et al.
Seminars in Thoracic and Cardiovascular Surgery|October 22, 2022
Benefit of adjuvant chemotherapy for resected pathologic N1 non-small cell lung cancer is unrecognized: A subgroup analysis of the JBR10 trialOmar Toubat, Li Ding, Keyue Ding, et al.
American Journal of Clinical Oncology|March 23, 2022
Patterns of Use of Stereotactic Body Radiation Therapy Compared With Surgery for Definitive Treatment of Primary Early-stage Non-small Cell Lung CancerJulie K Jang, Scott M Atay, Li Ding, et al.
Pageof 7